SUMMARY As part of an investigation into the practical problems of a maternal serum alphafetoprotein (AFP) neural tube defect (NTD) screening programme carried out in Mid Glamorgan, South Wales, between 1977 and 1979, obstetricians were recommended to refer women with high risk pregnancies directly for counselling, high resolution ultrasonography, and amniocentesis without first carrying out serum screening. Out of 15 687 pregnant women onethird attended too late to be screened. A total of 637 was classed as high risk, mostly at greater risk than 1 in 50 because of a previously affected pregnancy or an affected close relative. Compliance with recommended procedure was relatively low as many were screened. There were 10 pregnancies with a recurrence of NTD, of which one was not tested at all, two were not detected (one closed meningocele and one closed iniencephalic), and seven were detected and the pregnancies terminated. All the latter, as well as the iniencephalic, would have been detected from a serum AFP determination and a high resolution ultrasound scan alone. It is concluded that these investigations are sufficient for high risk pregnancies and that amniocentesis is not really cost effective or necessary unless either of these investigations is abnormal. As numbers in this study were small it is suggested that these conclusions should be tested in a larger study.
Prenatal diagnosis of neural tube defects following an ultrasound scan (USS) and amniocentesis has for over a decade been part of antenatal care for women at increased risk for NTD.1 Screening for these defects had become a possibility following the publication of the UK Collaborative Study in 19772 which suggested that 88% of open NTD would be detected at 16 to 18 weeks' gestation if 2 5 multiples above the median was used as the cut off point for maternal serum AFP. Since the publication of the report of the working party for screening neural tube defects (the Black Report),3 population screening for NTD has been increasingly undertaken in the United Kingdom.
In 1976 the Department of Health and Social Security and the Welsh Office provided funding for an interdisciplinary South Wales Anencephaly and Spina Bifida Study Group to examine the acceptability, effectiveness, and operational issues of maternal serum AFP screening under field conditions.4 In this investigation, obstetricians were also given the option of referring for prenatal diagnosis women known to be at increased risk for NTD5 because of a family history without first having serum AFP screening. This paper describes how this policy was followed in practice and how effective it turned out to be.
Methods
The investigation was mounted between January 1977 and August 1979 in Mid Glamorgan, a nonteaching Health Authority with a population of 540 000, and at the time of the study with a high prevalence (4-7/1000 births) of NTD. Included in the study were 15 687 women with complete information who were booked for confinement in the National Health Service maternity units (98.6% of all pregnancies in the area). Clinic midwives working with eight consultants in seven clinics identified the following groups of high risk mothers.
(1) Mothers who had previously had one or more pregnancies with a NTD. 57
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(3) Parents who themselves had spina bifida. (4) Parents with sibs who had NTD.
(5) Parents whose sib had a pregnancy with a NTD or where their parents, aunts, or uncles had a NTD.
It was recommended that subjects in these groups should be referred for genetic counselling and high resolution USS6 7 to a central assessment clinic organisation set up as part of the screening programme. This was followed in some cases with amniocentesis at 15 weeks or as soon as possible thereafter, without measuring maternal serum AFP. In the majority of cases referred to the central assessment clinic a blood sample for serum AFP estimation was also taken just before amniocentesis, but this was for research purposes and was not considered part of the screening procedure. For the last year of the study women in group 5 were no longer referred directly as the climate of opinion had changed about amniocentesis for this group (table  1) . Women with no family history of NTD had a blood sample taken for serum AFP estimation between 16 and 19 weeks. Those first attending after 19 weeks were considered to be too late for screening.
Obstetricians were not obliged to adhere to these recommended procedures and were at liberty to decide on their own policies, provided that these were known to the study group.
Results
In the Mid Glamorgan population of 15 687 pregnant women, there were 73 who had a pregnancy with NTD: 39 with anencephaly (or one of its variants) and 34 with spina bifida, seven of which were closed lesions. This is a prevalence of 4-7 per 1000 pregnancies that had reached 16 weeks' gestation (2.5 per 1000 for anencephaly and 2-2 per 1000 for spina bifida).
The accuracy with which women at high risk for NTD were identified by the antenatal clinical staff In only 72 instances was the recommended high risk policy of 'direct to USS and amniocentesis' strictly adhered to, including six women who first attended after the 19th week. Among these, one anencephalic pregnancy which was terminated was identified from both an abnormal USS and an abnormal amniotic fluid AFP level.
A total of 454 high risk women went through the maternal serum AFP screening procedure. Of these, 218 had no further investigations after a normal serum AFP was reported. However, among these was one woman who had a pregnancy with NTD. She had a normal serum AFP level at 18 weeks but then developed polyhydramnios at 32 weeks, had gross fetal abnormality on USS, and delivered an iniencephalic fetus with a closed lesion. One other woman had a grossly raised serum AFP level at 18 weeks which led to the termination of the pregnancy with the delivery of a fetus with a craniorachischisis.
A total of 156 women was referred for genetic counselling, USS, and amniocentesis after serum AFP screening had first been carried out. There were three pregnancies with NTD. In one anencephalic pregnancy the serum AFP level was interpreted as being within normal limits for 16 weeks, but the gestational dating was subsequently shown to have been only 12 weeks. USS, preamniocentesis serum, and the amniotic AFP levels were all grossly abnormal at 16 weeks and the pregnancy was terminated. The second anencepha- The compliance with the recommended procedure for high risk mothers was low (12%), making it difficult to evaluate the effectiveness of the option on its own. In practice, obstetricians were often reluctant to challenge high risk pregnancies, many of which in their experience would subsequently turn out to be normal. Furthermore, there was good reason to believe that the sensitivity was high,2 so they preferred instead to take a blood sample and wait for the result. In addition, many women had their serum AFP taken as part of the screening programme and were then sent for amniocentesis 
